The antifungal activity of posaconazole (SCH56592), a new triazole antifung
al, against stock cultures and fresh clinical isolates of a wide range of p
athogenic fungi was compared with that of itraconazole, fluconazole and amp
hotericin B. Posaconazole inhibited growth of all the fungal species tested
except Fusarium spp. at 1 mg/l or lower concentrations, showing a broad-sp
ectrum antifungal activity. The activities of posaconazole for all the fung
al species far surpassed those of fluconazole and were even superior to tho
se of itraconazole for Aspergillus spp. as well as for many other fungal sp
ecies. (C) 2001 Elsevier Science B.V. and International Society of Chemothe
rapy. All rights reserved.